statistiche ricercatore

Continente	#
NA - Nord America	666
AS - Asia	333
EU - Europa	292
SA - Sud America	48
AF - Africa	22
Continente sconosciuto - Info sul continente non disponibili	17
OC - Oceania	2
Totale	1.380

Nazione	#
US - Stati Uniti d'America	642
CN - Cina	136
SG - Singapore	89
IE - Irlanda	83
RU - Federazione Russa	47
IT - Italia	42
HK - Hong Kong	37
DE - Germania	32
BR - Brasile	31
VN - Vietnam	24
FR - Francia	20
GB - Regno Unito	17
ZA - Sudafrica	17
FI - Finlandia	14
CA - Canada	12
IN - India	9
PL - Polonia	8
BD - Bangladesh	7
TR - Turchia	7
AR - Argentina	6
JP - Giappone	6
MX - Messico	6
LT - Lituania	4
SE - Svezia	4
AT - Austria	3
BE - Belgio	3
CO - Colombia	3
ES - Italia	3
NL - Olanda	3
PK - Pakistan	3
SC - Seychelles	3
AU - Australia	2
EC - Ecuador	2
ID - Indonesia	2
JM - Giamaica	2
PE - Perù	2
PH - Filippine	2
UA - Ucraina	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
AM - Armenia	1
BA - Bosnia-Erzegovina	1
BY - Bielorussia	1
CH - Svizzera	1
CL - Cile	1
CR - Costa Rica	1
CW - ???statistics.table.value.countryCode.CW???	1
CZ - Repubblica Ceca	1
GE - Georgia	1
GR - Grecia	1
GT - Guatemala	1
IL - Israele	1
IQ - Iraq	1
IR - Iran	1
KZ - Kazakistan	1
ML - Mali	1
MN - Mongolia	1
MU - Mauritius	1
NI - Nicaragua	1
NP - Nepal	1
PT - Portogallo	1
SA - Arabia Saudita	1
SR - Suriname	1
SV - El Salvador	1
UZ - Uzbekistan	1
Totale	1.364

Nome	#
Inter-observer agreement on the morphology of screening-detected lung cancer: beyond pulmonary nodules and masses	177
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome	158
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3	146
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome	143
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1	142
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome	133
Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients	108
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk)	106
Unexpected Risk Profile of a Large Pediatric Population With Brugada Syndrome	102
Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy	90
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment-Authors' reply	75
Totale	1.380

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	32	0	0	0	0	0	0	0	2	2	4	4	20
2022/2023	199	16	14	11	12	11	22	0	9	99	0	4	1
2023/2024	83	17	12	3	4	4	16	9	5	2	0	3	8
2024/2025	220	10	13	2	3	11	23	10	16	64	11	23	34
2025/2026	504	37	23	45	61	73	23	80	24	45	46	27	20
2026/2027	161	15	48	34	49	15	0	0	0	0	0	0	0
Totale													1.380